Registration Deadline:
Event Contact:
Explore other Industry Opportunities:
Johnson & Johnson's challenge seeks novel AI/ML innovations that can transform drug discovery and development processes, with opportunities for global innovators who demonstrate interest in leveraging Singapore's innovation ecosystem.
Overview
- Award funding from total pool of up to $400,000
- Mentorship from experts across Johnson & Johnson
- Select awardees may receive JLABS Singapore membership (subject to terms and conditions)
- Focus on AI-driven tools and models for pharmaceutical research and development
- Opportunity to accelerate promising technologies with transformational potential
Priority Areas
- Foundation models and multi-omics capabilities: For uncovering novel biology
- Virtual disease models and validation platforms: To interrogate complex biological mechanisms
- Computer vision and digital health tools: That enable precision medicine
- Generative AI and agentic frameworks: To extract insights from large datasets, enhance scientific workflows, and boost R&D productivity
Eligibility & Requirements
- Open to innovators around the world with demonstrated interest in leveraging the Singapore ecosystem
- Must propose novel AI/ML innovation strategies and approaches to augmented science
- Excludes life science tools developers (equipment, devices, reagents) or medical devices
- Excludes contract research organizations
- Excludes patient or physician-facing apps (IoT/connected sensors, health counseling chatbots)
- Evaluated on strategic alignment, potential impact, novelty/differentiation, feasibility, resource planning, team quality, and Singapore ecosystem interest
Please note: Full RFP is attached in the "More Information" section of this page. Faculty and researchers interested in applying for these opportunities based on technologies developed or disclosed at Vanderbilt must submit their proposals through the CTTC.